Innate Pharma S.A. ADR

Business Description

Founded in 1999 and headquartered in Marseille, France, Innate Pharma is a clinical-stage biotechnology company focused on developing cancer treatments that work by activating the body's immune system. Its pipeline includes several antibody-based therapies targeting blood cancers and solid tumors, with key programs in late-stage clinical trials conducted in partnership with major pharmaceutical companies such as AstraZeneca, Sanofi, and Novo Nordisk. The company's research spans multiple approaches to fighting cancer, from blocking pathways that suppress immune responses to engaging natural killer cells to attack tumor cells.